BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 38439693)

  • 21. The future of radiotherapy in small animals - should the fractions be coarse or fine?
    Nolan MW; Dobson JM
    J Small Anim Pract; 2018 Sep; 59(9):521-530. PubMed ID: 29974465
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Companion Animal Model in Translational Oncology; Feline Oral Squamous Cell Carcinoma and Canine Oral Melanoma.
    Giuliano A
    Biology (Basel); 2021 Dec; 11(1):. PubMed ID: 35053051
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A One Health Perspective on the Human-Companion Animal Relationship with Emphasis on Zoonotic Aspects.
    Overgaauw PAM; Vinke CM; Hagen MAEV; Lipman LJA
    Int J Environ Res Public Health; 2020 May; 17(11):. PubMed ID: 32471058
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dosimetry and Radiobiology of Alpha-Particle Emitting Radionuclides.
    Sgouros G; Hobbs R; Josefsson A
    Curr Radiopharm; 2018; 11(3):209-214. PubMed ID: 29697036
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High dose lansoprazole combined with metronomic chemotherapy: a phase I/II study in companion animals with spontaneously occurring tumors.
    Spugnini EP; Buglioni S; Carocci F; Francesco M; Vincenzi B; Fanciulli M; Fais S
    J Transl Med; 2014 Aug; 12():225. PubMed ID: 25143012
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current Status of Radiopharmaceutical Therapy.
    St James S; Bednarz B; Benedict S; Buchsbaum JC; Dewaraja Y; Frey E; Hobbs R; Grudzinski J; Roncali E; Sgouros G; Capala J; Xiao Y
    Int J Radiat Oncol Biol Phys; 2021 Mar; 109(4):891-901. PubMed ID: 32805300
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypoxia-inducible factors--regulation, role and comparative aspects in tumourigenesis.
    Hansen AE; Kristensen AT; Law I; Jørgensen JT; Engelholm SA
    Vet Comp Oncol; 2011 Mar; 9(1):16-37. PubMed ID: 21303451
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The companion dog as a unique translational model for aging.
    Mazzatenta A; Carluccio A; Robbe D; Giulio CD; Cellerino A
    Semin Cell Dev Biol; 2017 Oct; 70():141-153. PubMed ID: 28803893
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spontaneously occurring tumors of companion animals as models for human cancer.
    Vail DM; MacEwen EG
    Cancer Invest; 2000; 18(8):781-92. PubMed ID: 11107448
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Monte Carlo approach to small-scale dosimetry of solid tumour microvasculature for nuclear medicine therapies with (223)Ra-, (131)I-, (177)Lu- and (111)In-labelled radiopharmaceuticals.
    Amato E; Leotta S; Italiano A; Baldari S
    Phys Med; 2015 Jul; 31(5):536-41. PubMed ID: 25979209
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative veterinary geroscience: mechanism of molecular, cellular, and tissue aging in humans, laboratory animal models, and companion dogs and cats.
    McKenzie BA
    Am J Vet Res; 2022 May; 83(6):. PubMed ID: 35524953
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preventive healthcare among dogs and cats in Chile is positively associated with emotional owner-companion animal bond and socioeconomic factors.
    Salgado-Caxito M; Benavides JA; Atero N; Córdova-Bürhle F; Ramos R; Fernandez M; Sapiente-Aguirre C; Mardones FO
    Prev Vet Med; 2023 Apr; 213():105882. PubMed ID: 36867925
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radiopharmaceutical therapy in the era of precision medicine.
    Sgouros G; Goldenberg DM
    Eur J Cancer; 2014 Sep; 50(13):2360-3. PubMed ID: 24953565
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Species differences in tumour responses to cancer chemotherapy.
    Lawrence J; Cameron D; Argyle D
    Philos Trans R Soc Lond B Biol Sci; 2015 Jul; 370(1673):. PubMed ID: 26056373
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of imaging-based dosimetry for personalising radiopharmaceutical therapy of cancer.
    Beauregard JM
    Cancer Imaging; 2022 Dec; 22(1):67. PubMed ID: 36494731
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overcoming Barriers to Radiopharmaceutical Therapy (RPT): An Overview From the NRG-NCI Working Group on Dosimetry of Radiopharmaceutical Therapy.
    Divgi C; Carrasquillo JA; Meredith R; Seo Y; Frey EC; Bolch WE; Zimmerman BE; Akabani G; Jacobson DA; Brown B; Davern SM; Hobbs RF; Humm J; Moros EG; Morse D; Papineni R; Zanzonico P; Benedict SH; Sgouros G
    Int J Radiat Oncol Biol Phys; 2021 Mar; 109(4):905-912. PubMed ID: 33309909
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Advances in veterinary radiation therapy: targeting tumors and improving patient comfort.
    LaRue SM; Custis JT
    Vet Clin North Am Small Anim Pract; 2014 Sep; 44(5):909-23. PubMed ID: 25174907
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biological carrier molecules of radiopharmaceuticals for molecular cancer imaging and targeted cancer therapy.
    Aerts A; Impens NR; Gijs M; D'Huyvetter M; Vanmarcke H; Ponsard B; Lahoutte T; Luxen A; Baatout S
    Curr Pharm Des; 2014; 20(32):5218-44. PubMed ID: 24606796
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Owner perceptions of radiotherapy treatment for veterinary patients with cancer.
    Smith PAD; Burnside S; Helm JR; Morris JS
    Vet Comp Oncol; 2019 Sep; 17(3):221-233. PubMed ID: 30663194
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Taking on cancer: treatment increases, improves for companion animals.
    Burns K
    J Am Vet Med Assoc; 2014 Jan; 244(2):140-4. PubMed ID: 24378021
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.